Universal Vaccines:
Our first universal vaccine has completed pre-clinical development in ferrets, pigs, mice, rats and human immune organoids, and is scheduled for human clinical trials to begin in 2025. It was awarded a Gates Foundation Grand Challenge: End the Pandemic Threat. Featured in Netflix docuseries Pandemic: How to Prevent an Outbreak.
Broad-Spectrum Anti-Infectives:
Multidrug-resistant bacteria are reversing a century of medical progress made possible by the antibiotic revolution. We develop universal vaccines, as well as broad-spectrum antibody programs, in pre-clinical development and supported by the Medical Technology Enterprise Consortium, the Naval Medical Research Center, the Walter Reed Army Institute of Research, and CRADAs with the United States Army Medical Research Institute of Infectious Diseases.